Results 91 to 100 of about 67,405 (197)

Vaccination Coverage and Factors Associated With Incomplete Vaccination Schedules in Children Under 5 in a Peripheral Area of the Federal District of Brazil

open access: yesPublic Health Nursing, Volume 43, Issue 3, Page 543-553, May/June 2026.
ABSTRACT Objective To estimate vaccination coverage (VC) and analyze the factors associated with the incomplete vaccination schedule (IVS) in children under 5 years of age in two Basic Health Units in the Federal District of Brazil. Design A cross‐sectional study.
Ivea Rayane Mendes Nicacio Viana   +1 more
wiley   +1 more source

Pharmacovigilance assessment of adverse events following yellow fever vaccination: Disproportionality analysis of VAERS reports, 2015–2025

open access: yesHuman Vaccines & Immunotherapeutics
Yellow fever vaccination remains the most effective strategy for preventing infection in endemic and travel-associated settings, yet rare severe adverse events such as viscerotropic and neurotropic disease continue to raise safety concerns. Adverse event
Guojun Liang, Qiong Liu, Yang Song
doaj   +1 more source

Unbiased Metagenomic Sequencing for Pediatric Meningitis in Bangladesh Reveals Neuroinvasive Chikungunya Virus Outbreak and Other Unrealized Pathogens. [PDF]

open access: yes, 2019
The burden of meningitis in low-and-middle-income countries remains significant, but the infectious causes remain largely unknown, impeding institution of evidence-based treatment and prevention decisions.
Crawford, Emily D.   +25 more
core   +2 more sources

Spatiotemporal Early Warning of Human Brucellosis in Hubei Province Using Coupled Ecological‐Time Series Models

open access: yesZoonoses and Public Health, Volume 73, Issue 3, Page 244-261, May 2026.
ABSTRACT Introduction This study explored transmission patterns of brucellosis in Hubei Province, a Class II region in China, through analysis of spatiotemporal distribution and environmental factors to provide evidence for precise prevention. Methods We analysed epidemiological data from Hubei Province (2010–2023), including human cases, demographics,
Qi Chen   +7 more
wiley   +1 more source

Experimental DNA-Launched Live-Attenuated Vaccines Against Yellow Fever

open access: yesЭпидемиология и вакцинопрофилактика, 2019
Background DNA-launched vaccine is “manufactured” in vaccinated individuals and does not require traditional vaccine manufacturing facility and technology. Goals.
P. Pushko   +3 more
doaj   +1 more source

Yellow fever cases in Asia: primed for an epidemic

open access: yesInternational Journal of Infectious Diseases, 2016
There is currently an emerging outbreak of yellow fever in Angola. Cases in infected travellers have been reported in a number of other African countries, as well as in China, representing the first ever documented cases of yellow fever in Asia. There is
Sean Wasserman   +2 more
doaj   +1 more source

Vaccination and transfusion safety at the time of expanding use of live attenuated vaccines

open access: yes
Vox Sanguinis, EarlyView.
Pierre Tiberghien   +4 more
wiley   +1 more source

Global Health Security in an Era of Explosive Pandemic Potential [PDF]

open access: yes, 2017
Pandemics pose a significant risk to security, economic stability, and development. Annualized expected losses from pandemics are estimated at $60 billion per year. Despite the certainty and magnitude of the threat, the global community has significantly
Ayala, Ana, Gostin, Lawrence O.
core   +1 more source

Vaccines licensed and in clinical trials for the prevention of dengue

open access: yesHuman Vaccines & Immunotherapeutics, 2017
Dengue has become a major global public health threat with almost half of the world's population living in at-risk areas. Vaccination would likely represent an effective strategy for the management of dengue disease in endemic regions, however to date ...
J. Torresi, G. Ebert, M. Pellegrini
doaj   +1 more source

Home - About - Disclaimer - Privacy